Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series

Before the introduction of antipsychotic medications, Electroconvulsive Therapy (ECT) was considered one of the first-line treatments for psychotic disorders. Although ECT is still recommended for certain patients with psychosis, the widespread use of antipsychotic drugs has made it less commonly ut...

Full description

Bibliographic Details
Main Authors: Divya Devanathan, Avudaiappan Sankaran, Suriya Kumar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/18934/68592_CE[Ra1]_F(SS)_QC&Ref(SHK_SS)_(AKA_DK)_PFA(AKA_KM)_PN(KM).pdf
_version_ 1827382629600591872
author Divya Devanathan
Avudaiappan Sankaran
Suriya Kumar
author_facet Divya Devanathan
Avudaiappan Sankaran
Suriya Kumar
author_sort Divya Devanathan
collection DOAJ
description Before the introduction of antipsychotic medications, Electroconvulsive Therapy (ECT) was considered one of the first-line treatments for psychotic disorders. Although ECT is still recommended for certain patients with psychosis, the widespread use of antipsychotic drugs has made it less commonly utilised. However, the combination of ketamine and dexmedetomidine (Ketodex) may prove beneficial in controlling the haemodynamic response and preventing emergent confusion due to their opposing drug actions. Nonetheless, the use of Ketodex in patients with psychosis undergoing ECT has not been thoroughly explored. This series presents cases of five patients (22 years female, 25 years female, 28 years male, 19 years female and 25 years female patients) who underwent 25 sessions of ECT with the ketamine-dexmedetomidine combination. All patients demonstrated good cardiovascular stability without experiencing emergent confusion. Based on these findings, the study concludes that the combination of ketamine and dexmedetomidine is both effective and safe for patients with psychosis undergoing ECT.
first_indexed 2024-03-08T14:24:16Z
format Article
id doaj.art-8122709ddcc84cd18f28070a64629aae
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-03-08T14:24:16Z
publishDate 2024-01-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-8122709ddcc84cd18f28070a64629aae2024-01-13T11:14:26ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2024-01-011801010310.7860/JCDR/2024/68592.18934Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case SeriesDivya Devanathan0Avudaiappan Sankaran1Suriya Kumar2Assistant Professor, Department of Anaesthesiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pondicherry, India.Professor, Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pondicherry, India.Assistant Professor, Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pondicherry, India.Before the introduction of antipsychotic medications, Electroconvulsive Therapy (ECT) was considered one of the first-line treatments for psychotic disorders. Although ECT is still recommended for certain patients with psychosis, the widespread use of antipsychotic drugs has made it less commonly utilised. However, the combination of ketamine and dexmedetomidine (Ketodex) may prove beneficial in controlling the haemodynamic response and preventing emergent confusion due to their opposing drug actions. Nonetheless, the use of Ketodex in patients with psychosis undergoing ECT has not been thoroughly explored. This series presents cases of five patients (22 years female, 25 years female, 28 years male, 19 years female and 25 years female patients) who underwent 25 sessions of ECT with the ketamine-dexmedetomidine combination. All patients demonstrated good cardiovascular stability without experiencing emergent confusion. Based on these findings, the study concludes that the combination of ketamine and dexmedetomidine is both effective and safe for patients with psychosis undergoing ECT. https://www.jcdr.net/articles/PDF/18934/68592_CE[Ra1]_F(SS)_QC&Ref(SHK_SS)_(AKA_DK)_PFA(AKA_KM)_PN(KM).pdfketaminedexmedetomidineanti-psychoticmedications
spellingShingle Divya Devanathan
Avudaiappan Sankaran
Suriya Kumar
Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
Journal of Clinical and Diagnostic Research
ketamine
dexmedetomidine
anti-psychotic
medications
title Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
title_full Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
title_fullStr Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
title_full_unstemmed Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
title_short Ketodex for Electroconvulsive Therapy in Patients with Psychotic Disorders: A Case Series
title_sort ketodex for electroconvulsive therapy in patients with psychotic disorders a case series
topic ketamine
dexmedetomidine
anti-psychotic
medications
url https://www.jcdr.net/articles/PDF/18934/68592_CE[Ra1]_F(SS)_QC&Ref(SHK_SS)_(AKA_DK)_PFA(AKA_KM)_PN(KM).pdf
work_keys_str_mv AT divyadevanathan ketodexforelectroconvulsivetherapyinpatientswithpsychoticdisordersacaseseries
AT avudaiappansankaran ketodexforelectroconvulsivetherapyinpatientswithpsychoticdisordersacaseseries
AT suriyakumar ketodexforelectroconvulsivetherapyinpatientswithpsychoticdisordersacaseseries